The Issuer advises that further to the notice below and following confirmation of the correct number of shares for Novartis (Switzerland, constituent), FTSE announces that the Technical notice should have read as follows:

Novartis (Switzerland): Shares in Issue Update
FTSEurofirst Index Series

29 July 2008

Following the receipt of updated share information for Novartis (Switzerland, constituent), resulting in a market capitalisation change greater than USD 2bn, FTSE and Euronext announce the following changes:

INDEX	CHANGE	EFFECTIVE FROM START OF TRADING
FTSEurofirst 300 Index	Novartis (Switzerland, 7103065) will remain in the index with a decreased shares in issue of 2,263,300,000 and an unchanged investability weighting of 100%.	4 August 2008

For index related enquiries or further information about FTSE please contact:

Client Services in UK:	Tel: +44 (0) 20 7866 1810
Client Services in US:	Tel: +1 888 747 FTSE (3873) or +1 212 641 6165
Client Services in Asia Pacific:	Tel: +852 2230 5803 or +65 6223 3738 or +81 3 3581 2811

Or, email your enquiries to info@ftseurofirst.com or visit our website at www.ftseurofirst.com